These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26511495)

  • 1. Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab.
    Frenard C; Peuvrel L; Jean MS; Brocard A; Knol AC; Nguyen JM; Khammari A; Quereux G; Dreno B
    J Neurooncol; 2016 Jan; 126(2):355-60. PubMed ID: 26511495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
    Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT
    Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
    Di Giacomo AM; Ascierto PA; Pilla L; Santinami M; Ferrucci PF; Giannarelli D; Marasco A; Rivoltini L; Simeone E; Nicoletti SV; Fonsatti E; Annesi D; Queirolo P; Testori A; Ridolfi R; Parmiani G; Maio M
    Lancet Oncol; 2012 Sep; 13(9):879-86. PubMed ID: 22894884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
    Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
    Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.
    Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A
    Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery.
    Tazi K; Hathaway A; Chiuzan C; Shirai K
    Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
    Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ
    Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
    Margolin K; Ernstoff MS; Hamid O; Lawrence D; McDermott D; Puzanov I; Wolchok JD; Clark JI; Sznol M; Logan TF; Richards J; Michener T; Balogh A; Heller KN; Hodi FS
    Lancet Oncol; 2012 May; 13(5):459-65. PubMed ID: 22456429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.
    Queirolo P; Spagnolo F; Ascierto PA; Simeone E; Marchetti P; Scoppola A; Del Vecchio M; Di Guardo L; Maio M; Di Giacomo AM; Antonuzzo A; Cognetti F; Ferraresi V; Ridolfi L; Guidoboni M; Guida M; Pigozzo J; Chiarion Sileni V
    J Neurooncol; 2014 May; 118(1):109-16. PubMed ID: 24532241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).
    Forschner A; Eichner F; Amaral T; Keim U; Garbe C; Eigentler TK
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):533-540. PubMed ID: 27878363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
    Schartz NE; Farges C; Madelaine I; Bruzzoni H; Calvo F; Hoos A; Lebbé C
    Melanoma Res; 2010 Jun; 20(3):247-50. PubMed ID: 20216240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids.
    Chasset F; Pages C; Biard L; Roux J; Sidina I; Madelaine I; Basset-Seguin N; Viguier M; Madjlessi-EzrA N; Schneider P; Bagot M; Resche-Rigon M; Lebbe C
    Eur J Dermatol; 2015; 25(1):36-44. PubMed ID: 25500362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.
    Sachpekidis C; Larribere L; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A; Hassel JC
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):386-96. PubMed ID: 25359635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
    Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
    Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review.
    Spagnolo F; Picasso V; Lambertini M; Ottaviano V; Dozin B; Queirolo P
    Cancer Treat Rev; 2016 Apr; 45():38-45. PubMed ID: 26975020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in metastatic malignant melanoma: ipilimumab followed by vemurafenib in a patient with brain metastasis.
    Balakan O; Süner A; Yiğiter R; Balakan T; Sirikçi A; Sevinç A
    Intern Med; 2012; 51(19):2819-23. PubMed ID: 23037483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.
    Thompson JA; Hamid O; Minor D; Amin A; Ron IG; Ridolfi R; Assi H; Berman D; Siegel J; Weber JS
    J Immunother; 2012 Jan; 35(1):73-7. PubMed ID: 22130164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipilimumab and whole brain radiation therapy for melanoma brain metastases.
    Gerber NK; Young RJ; Barker CA; Wolchok JD; Chan TA; Yamada Y; Friguglietti L; Beal K
    J Neurooncol; 2015 Jan; 121(1):159-65. PubMed ID: 25273687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.
    Basnet A; Saad N; Benjamin S
    Anticancer Res; 2016 Sep; 36(9):4795-8. PubMed ID: 27630330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipilimumab and radiation therapy for melanoma brain metastases.
    Silk AW; Bassetti MF; West BT; Tsien CI; Lao CD
    Cancer Med; 2013 Dec; 2(6):899-906. PubMed ID: 24403263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.